The survival kinases Akt and Pim as potential pharmacological targets

被引：359
|
作者：
Amaravadi, R [1 ]
Thompson, CB [1 ]
机构：
[1] Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol & Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2005年 / 115卷 / 10期
关键词：
D O I：
10.1172/JCI26273
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phosphorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT-dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases.
引用
收藏
页码：2618 / 2624
页数：7
相关论文
共 50 条
  • [31] Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential
    Giorgio Cozza
    Cristina Girardi
    Alessandro Ranchio
    Graziano Lolli
    Stefania Sarno
    Andrzej Orzeszko
    Zygmunt Kazimierczuk
    Roberto Battistutta
    Maria Ruzzene
    Lorenzo A. Pinna
    Cellular and Molecular Life Sciences, 2014, 71 : 3173 - 3185
  • [32] TARGETING CAP-DEPENDENT TRANSLATION TO BYPASS PRO-SURVIVAL SIGNALING BY AKT AND THE PIM FAMILY KINASES IN NON-HODGKIN LYMPHOMA
    Schatz, J. H.
    Teruya-Feldstein, J.
    Jiang, M.
    Zelenetz, A.
    Wendel, H.
    ANNALS OF ONCOLOGY, 2011, 22 : 136 - 136
  • [33] Protein kinases as potential anticandidal drug targets
    Singh, Shweta
    Rehman, Suriya
    Fatima, Zeeshan
    Hameed, Saif
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2020, 25 : 1412 - 1432
  • [34] Targeting PIM and AKT kinases impairs tumor growth and improves overall survival in a murine model of advanced castration-resistant prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi Ando
    Sato, Noriko
    Davies, Barry R.
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2018, 78 (13)
  • [35] A review on PIM kinases in tumors
    Arrouchi, Housna
    Lakhlili, Wiame
    Ibrahimi, Azeddine
    BIOINFORMATION, 2019, 15 (01) : 40 - 45
  • [36] PIM Kinases in Multiple Myeloma
    Wu, Jian
    Chu, Emily
    Kang, Yubin
    CANCERS, 2021, 13 (17)
  • [37] Co-targeting of AKT and Pim kinases in mouse PTEN-deficient prostate cancer
    De Velasco, Marco A.
    Sugimoto, Koichi
    Kura, Yurie
    Ando, Naomi
    Sato, Noriko
    Sakai, Kazuko
    Davies, Barry R.
    Huszar, Dennis
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2017, 77
  • [38] The PIM kinases in hematological cancers
    Alvarado, Yesid
    Giles, Francis J.
    Swords, Ronan T.
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (01) : 81 - 96
  • [39] PIM kinases in trophoblast cells
    Photini, Stella M.
    Chaiwangyen, Wittaya
    Al-kawlani, Boodor
    Favaro, Rodolfo
    Schleussner, Ekkehard
    Morales-Prieto, Diana M.
    Markert, Udo R.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2016, 115 : 83 - 83
  • [40] PIM KINASES IN TROPHOBLAST CELLS
    Photini, Stella M.
    Chaiwangyen, Wittaya
    Al-Kawlani, Boodor
    Morales-Prieto, Diana M.
    Schleussner, Ekkehard
    Markert, Udo R.
    PLACENTA, 2016, 45 : 81 - 81
12345